Government crackdown and legal entanglements take all the fun out of the Medicare Advantage plan bonanza.
By Wolf Richter for WOLF STREET.
Humana is one of the big health insures with Medicare Advantage Plans that have come under intense scrutiny from this Administration, from the prior administration, from Congress, from legal actions, and from investigative reports in the media, amid allegations of dramatically overbilling Medicare. These insurers are facing a full-blown government crackdown.
But it was so sweet while it lasted, generating huge profits, big revenue gains, and a massive run-up of the price of the stock: Humana’s shares – along with others in that arena – shot higher and higher from 2017 through 2022. But amid that crackdown, revenue growth has stalled over the past few quarters, and Humana posted a big loss in February.
Humana’s shares [HUM], which…



